Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.83 USD | +0.52% | +3.37% | -9.61% |
May. 20 | Foghorn Therapeutics Prices $110 Million Offering of Shares, Pre-Funded Warrants | MT |
May. 06 | Foghorn Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 116
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medicines
100.0
%
| 19 | 100.0 % | 34 | 100.0 % | +77.63% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 19 | 100.0 % | 34 | 100.0 % | +77.63% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 17-04-30 | |
Douglas Cole
FOU | Founder | 63 | 15-09-30 |
Fanny Cavalié
COO | Chief Operating Officer | 46 | - |
Steven Bellon
CTO | Chief Tech/Sci/R&D Officer | 59 | 16-05-31 |
Chief Tech/Sci/R&D Officer | 53 | 23-09-10 | |
Andrew Germain
LAW | General Counsel | - | 19-12-31 |
Saurabh Sewak
PRN | Corporate Officer/Principal | - | 21-12-31 |
Carlos Costa
HRO | Human Resources Officer | 51 | - |
Michael LaCascia
LAW | General Counsel | 59 | 20-11-11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Simba Gill
BRD | Director/Board Member | 60 | 17-06-30 |
Douglas Cole
FOU | Founder | 63 | 15-09-30 |
B. Parshall
BRD | Director/Board Member | 70 | 22-08-15 |
Ian Smith
BRD | Director/Board Member | 58 | 21-04-26 |
Adam Koppel
BRD | Director/Board Member | 54 | 17-06-30 |
Thomas Lynch
BRD | Director/Board Member | 63 | 22-10-26 |
Director/Board Member | 69 | 17-03-31 | |
Scott Biller
BRD | Director/Board Member | 68 | 20-01-08 |
Chief Executive Officer | 49 | 17-04-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 55,328,655 | 44,774,843 ( 80.93 %) | 0 | 80.93 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.61% | 323M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- FHTX Stock
- Company Foghorn Therapeutics Inc.